Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88021314 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Michael J. McCue |
Attorney Docket Number | 155500-00234 |
Law Office Assigned | N80 |
Employee Name | HASFORD, SARAH P |
2018-06-29 | Application Filed |
2018-08-27 | Location: TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED |
2018-08-27 | Status: Live/Pending |
2019-01-08 | Transaction Date |
2019-05-07 | Published for Opposition |
Owner: | ![]() |
Address | 9922 Jefferson Boulevard Culver City DE 90232 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 40 |
U.S. Codes: | 100,103,106 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Research consultation, research and development services both in the field of hematology, immunology, cancer research, developmental biology and life science, biotechnology, medical technology, cell culture, tissue engineering, regenerative medicine, immunotherapy, immunomodulation, control of the inflammation and of the immune system, vaccine production, viral vectors production; extracellular vesicles production; medical and scientific laboratory services, namely, contract assays services and proficiency testing services both relating to research and development services in the field of hematology, immunology, cancer research, developmental biology and life science; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; biotechnology laboratory services; analysis of biological samples; production of therapeutical cellular products, active ingredients production for cell based therapy; scientific laboratory services in the field of cell expansion technology for derivation, expansion, transformation, and multiplication of cells; experimental and research services for diagnostic processes or therapeutic applications for human or veterinary applications for use in laboratory, industrial or clinical centers |
Mark | Serial Number | Relationship Number |
---|---|---|
NANTWORKS | 85076089 | 4407353 |
NANTHEALTH | 85982778 | 4638026 |
NANTCLOUD | 85610653 | 4973372 |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-07-03 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-07-06 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-08-16 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2018-08-27 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2018-08-27 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-08-27 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-02-26 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-02-26 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-02-27 | 9 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-03-05 | 10 CNSA P: |
ASSIGNED TO LIE | 2019-03-25 | 11 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-04-17 | 12 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-05-07 | 13 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-05-07 | 14 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-07-02 | 15 NOAM E:E-Mail |
ASSIGNED TO EXAMINER | 2019-08-16 | 16 DOCK D:Assigned to Examiner |
TEAS EXTENSION RECEIVED | 2019-12-18 | 17 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2019-12-18 | 18 EXT1 S: |
EXTENSION 1 GRANTED | 2019-12-18 | 19 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-20 | 20 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-06-25 | 21 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2020-06-25 | 22 EXT2 S: |
EXTENSION 2 GRANTED | 2020-06-25 | 23 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-06-27 | 24 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2021-01-03 | 25 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2021-01-03 | 26 EXT3 S: |
EXTENSION 3 GRANTED | 2021-01-03 | 27 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-01-05 | 28 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2021-07-02 | 29 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2021-07-02 | 30 EXT4 S: |
EXTENSION 4 GRANTED | 2021-07-02 | 31 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-07-06 | 32 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2022-01-03 | 33 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-01-12 | 34 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2022-01-03 | 35 EXT5 S: |
EXTENSION 5 GRANTED | 2022-01-12 | 36 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-01-13 | 37 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2022-06-30 | 38 EISU I:Incoming Correspondence |
USE AMENDMENT FILED | 2022-06-30 | 39 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2022-07-05 | 40 SUPC I:Incoming Correspondence |
SU - NON-FINAL ACTION - WRITTEN | 2022-08-01 | 41 CNRT W: |
NON-FINAL ACTION E-MAILED | 2022-08-01 | 42 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-08-01 | 43 GNRN O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2023-02-13 | 44 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2023-02-13 | 45 MAB2 O:Outgoing Correspondence |
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2023-02-13 | 46 MAB2 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.